Skip to main content
2026 Global Regulatory Strategies Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Kingman Ng, PhD

Executive Director, Global Regulatory Affairs CMC
Eli Lilly and Company

Kingman Ng, Ph.D., is currently an Executive Director with Global Regulatory Affairs – Chemistry Manufacturing & Controls (GRA-CMC) at Eli Lilly and Company focus on supporting commercial parenteral drug product. He also has extensive experience in supporting clinical trial, market registration, and post-approval submissions in China. Before he joined GRA CMC, Kingman has over 20 years of industry experience in biologics formulation and drug product development including vaccines. His career spans roles at Eli Lilly & Company and Novartis Vaccines where he demonstrated technical leadership and expertise in parenteral drug product to advance the portfolio under acceleration development. He has contributed to the chapter "Pharmaceutical Development Studies and Manufacturing Experience" in the book "Fundamentals of Pharmaceutical And Biologics Regulations: A Global Perspective" published by RAPS in 2023. Kingman obtained his PhD in biophysical sciences from University of Minnesota. He is also a certified Marshall Goldsmith Stakeholder Centered coach.

Presentation(s):

Email Kingman